Sigilon Therapeutics
2 Followers
About
Sigilon Therapeutics’ mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases.
- Website
- Headquarters
- Industry
- Social
Org chart
View org chart
Rogerio Vivaldi Coelho
President and CEO
Rogerio Vivaldi Coelho
Collapse
Deya Corzo
Chief Medical Officer
Matthew Kowalsky
Chief Legal Officer
Philip Ashton-Rickardt
Chief Scientific Officer
Martha Rook
Chief Technical Operations Officer
Vanya Sagar
CHRO
Josias Pontes
VP, Head of Finance
Susan Drapeau
VP, Head of Device and Delivery Engineering
Hozefa Bandukwala
VP, Platform Innovation
Robert Windsor Jr.
VP, Head of Investor Relations
Jiang Wu
VP, Head of Bioanalytical & CMC Analytical Development
Bernd Kullmann
VP, Head of Manufacturing & Supply Chain
Teams
View all (0)No teams yet!
Jobs
View all (0)No jobs yet!
Wires
View all (0)No wires yet!
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.